➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Merck
Colorcon
Medtronic
Moodys

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

SIMULECT Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for SIMULECT

Identify potential brand extensions & biosimilar entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
City of Hope Medical CenterPhase 2
Peking University People's HospitalPhase 4

See all SIMULECT clinical trials

Recent Litigation for SIMULECT

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
2017-12-20
2012-09-25

See all SIMULECT litigation

Patent Text Search: US Patents for SIMULECT

These patents were identified by searching patent claims

Supplementary Protection Certificates for SIMULECT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
93138 Luxembourg   Get Started Free PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326
132016000070123 Italy   Get Started Free PRODUCT NAME: RITUXIMAB IN ASSOCIAZIONE CON IALURONIDASI RICOMBINANTE UMANA - SOLUZIONE PER INIEZIONE SOTTOCUTANEA(MABTHERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/98/067/001-003, 20140326
300753 Netherlands   Get Started Free PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
2011C/041 Belgium   Get Started Free PRODUCT NAME: BELATACEPT; AUTHORISATION NUMBER AND DATE: EU/1/11/694/001 20110623
122016000049 Germany   Get Started Free PRODUCT NAME: RITUXIMAB UND REKOMBINANTE HUMANE HYALURONIDASE; NAT. REGISTRATION NO/DATE: EU/1/98/067/003 20140321; FIRST REGISTRATION: EU EU/1/98/067/003 20140621
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.